At the beginning of this week the FDA unveiled four new and updated guidance targeting vaccines, drugs and biologics, monoclonal antibodies and diagnostic tests. to address the impact of COVID-19 variants on the efficacy and performance of their products……
By: Snell & Wilmer
SOURCE: Personal Injury & Products Liability RSS Feed | JD Supra Law News – Read entire story here.